Atlas Venture — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
RNA-editing therapeutics company using its OPERA technology platform.
BiotechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)Ommer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)Jean-Francois Formela(Director)
Board seatJean-François Formela· per SEC Form D
BiotechBoston, US
Gary Glick(Executive Officer, Director)Shelley Chu(Director)Jean-Francois Formela(Director)John Leonard(Director)
Board seatJean-François Formela· per SEC Form D · filed Dec 2019
BiotechBoston, US
Jean-Francois Formela(Director)John Leonard(Director)Gary Glick(Executive Officer, Director)Shelley Chu(Director)
Board seatJean-François Formela· per SEC Form D · filed Dec 2019
BiotechBoston, US
Gary Glick(Executive Officer, Director)Jean-Francois Formela(Director)John Leonard(Director)Shelley Chu(Director)
Board seatJean-François Formela· per SEC Form D · filed Dec 2019
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.